Queen Mary University of London | GenomeWeb

Queen Mary University of London

British researchers examined ash dieback disease susceptibility markers among ash trees in the UK and continental Europe.

Exome sequencing data for hundreds of testicular germ cell tumor patients led to the discovery of rare mutations affecting cilia-microtubule genes.

Tapping data for hundreds of thousands of individuals, three teams uncovered overlaps between blood pressure and other metabolic and immune traits.

Investigators looked at potential health impacts for the rare, homozygous loss-of-function mutations they detected in 3,200 British-Pakistani individuals.

Three Markers

A Queen Mary University of London-led team reports on a three-protein biomarker panel for early stage pancreatic cancer.

NEW YORK (GenomeWeb) – A new study suggests related, but previously undescribed, Ranavirus species are wreaking havoc on a range of amphibian hosts in Spain.

NEW YORK (GenomeWeb News) – A new Nature Genetics study hints that a combination of ineffective control strategies and new adaptations by Mycobacterium tuberculosis populations have con

NEW YORK (GenomeWeb News) – Direct transmission of Clostridium difficile from one patient to another may be a less common mode of infection than anticipated in some healthcare settings, according to a new Genome Biology study.

By adapting existing next-generation sequencing strategies to profile DNA methylation patterns in small amounts of starting material, a team from the UK, Sweden, and Germany hopes to garner longitudinal epigenetic information from newborn bloodspot samples that may eventually tur

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.